Baiyu pharmaceutical Co. Ltd. donated medicines that worth more than 8.35 to 41 hospitals in Hubei Province At 11:00 a.m. on March 2, 2020, in Baiyu’s CDHT factory, three trucks loaded with medicines that worth more than 8.35 million yuan drove to Hubei Province. Those medicines are
On January 18, 2021, Baiyu received the notice issued by NMPA(National Medical Products Administration), saying that Baiyu's Pantoprazole Sodium injection has officially passed the Consistency Evaluation, which means NMPA has accredited that Baiyu's Pantoprazole Sodium injection has the same o
On March 12, 2017, Baiyu’s key product Ginkgolide injection was awarded “Innovative Drugs with Most Clinical Value(Herbal Medicinal Products)” in the Second Selection Activity of Most Innovative Brand in Chinese Pharmaceutical Industry. Ginkgolide injection is the only herbal products which
Ginkgolide injection have successfully entered National Essential Medicine List. The entrance enables Ginkgolide injection benefit more patients in China. It is a milestone for Baiyu, we would like to deliver our many thanks to our partners, our customers and we will continue to r
Baiyu was awarded “Enterprises with the Most Investment Value in Chinese Pharmaceutical Industry 2017” by China National Pharmaceutical Industry Information Center on the National Industrial Information Annual Meeting on 2nd of September. This is Baiyu’s third time of awarding since 201
On May 20th, Baiyu donated ¥1,7500 to The First Children welfare home of Wenjiang as a gift for this year’s Children’s Day. The donation is composed of fundraising amongst Baiyu employees reaching to ¥10,000 and the company giving of ¥7,500. In the speed gave by Mr. Zhou, the representativ
